🔗 Share this article

An underground economy for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.

Investigational Drug Gaining Traction Via Social Media

The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its alleged fat-burning effects. Viewers are urged to message these accounts privately for supplier links, while also obtaining promotional offers.

Thriving Trade on Messaging Platforms

Separately, a flourishing trade exists on Telegram, where groups with thousands of members share “before and after” photos, injection guides and assertions of next-day UK delivery. Sellers promote the substance there before redirecting customers to WhatsApp for purchases.

Learning About The Experimental Drug

This medication is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could help patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.

Healthcare Experts Voice Concerns

Nevertheless, physicians and chemists have cautions that the sale of what is still an unapproved drug in the UK is worrisome and could result in individuals administering products of uncertain source.

Some professionals said the popularity for the experimental drug could be linked to the rising price of licensed slimming products such as Mounjaro.

Regulatory Position and Implementation

Selling the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved drug that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Some influencers try to sidestep the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still violate pharmaceutical, advertising, and customer laws, risking penalties, prosecution or imprisonment.

Platform Reaction and Content Elimination

Based on the social media company, the service has removed violative material and prohibited associated keywords and search suggestions. The organization stated it was committed to maintaining the service safe and investing in strengthening compliance measures.

Online Marketplace Activities

Research also discovered groups with up to 9,000 members selling retatrutide using Telegram's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” immediately displays groups with numerous of users, filled with photos of slimming results, positive testimonials and step-by-step instructions for mixing or administering at home.

After minutes of joining one group, a vendor shared contact information, where the majority of transactions occur. The vendor sent an guidebook and promised shipping within 48 hours. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one inquired about body mass, medical conditions or previous experience.

Item Details and Pricing

Inside these groups, posts show black plastic parcels with Royal Mail stickers, stating to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at residence with purified liquid, or pre-filled injectors typically sold at 160 pounds for 20 milligrams. When asked how long a injector should be used, vendors give contradictory responses varying between a several days to “depends on your body”.

Service Oversight and Security Actions

A spokesperson for the messaging service stated it actively moderated harmful content on its platform including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are administering materials they cannot confirm. Although the science behind this drug is sound, these online products may not contain what they claim,” stated a pharmacy expert, the head of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor connected the increase in interest to current price rises for authorized slimming drugs such as Mounjaro. “With prices rising, individuals are using social media. But counterfeit treatments are extremely risky. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she said.

Her team has previously seen patients harmed by self-injection from unconfirmed sources. “We understand the disappointment, but buying from messaging apps or WhatsApp is gambling with your well-being,” said the doctor. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Position

A representative from the pharmaceutical company stated the substance was in third stage clinical trials and had not been evaluated or authorized by any government authority globally. “Therefore at this point no one can sell [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a Lilly experimental product not yet authorized … may expose users to possibly serious health risks”.